BIOGEN INC (1BIIB.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BIIB - US09062X1037 - Common Stock
144.45 EUR
-6.45 (-4.27%)
Overall 1BIIB gets a fundamental rating of 6 out of 10. We evaluated 1BIIB against 85 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making 1BIIB a very profitable company, without any liquidiy or solvency issues. 1BIIB is valued quite cheap, but it does not seem to be growing. These ratings would make 1BIIB suitable for value investing!
1. Profitability
1.1 Basic Checks
- 1BIIB had positive earnings in the past year.
- In the past year 1BIIB had a positive cash flow from operations.
- 1BIIB had positive earnings in each of the past 5 years.
- 1BIIB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- 1BIIB's Return On Assets of 5.51% is amongst the best of the industry. 1BIIB outperforms 82.95% of its industry peers.
- 1BIIB has a better Return On Equity (8.84%) than 81.82% of its industry peers.
- 1BIIB has a Return On Invested Capital of 9.70%. This is amongst the best in the industry. 1BIIB outperforms 87.50% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1BIIB is in line with the industry average of 11.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.51% | ||
| ROE | 8.84% | ||
| ROIC | 9.7% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
- 1BIIB has a Profit Margin of 15.98%. This is amongst the best in the industry. 1BIIB outperforms 82.95% of its industry peers.
- In the last couple of years the Profit Margin of 1BIIB has declined.
- The Operating Margin of 1BIIB (28.50%) is better than 86.36% of its industry peers.
- In the last couple of years the Operating Margin of 1BIIB has declined.
- 1BIIB has a Gross Margin of 75.24%. This is in the better half of the industry: 1BIIB outperforms 67.05% of its industry peers.
- In the last couple of years the Gross Margin of 1BIIB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.5% | ||
| PM (TTM) | 15.98% | ||
| GM | 75.24% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
- 1BIIB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, 1BIIB has more shares outstanding
- Compared to 5 years ago, 1BIIB has less shares outstanding
- 1BIIB has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.25 indicates that 1BIIB is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.25, 1BIIB is in the better half of the industry, outperforming 70.45% of the companies in the same industry.
- 1BIIB has a debt to FCF ratio of 2.78. This is a good value and a sign of high solvency as 1BIIB would need 2.78 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.78, 1BIIB belongs to the top of the industry, outperforming 84.09% of the companies in the same industry.
- 1BIIB has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
- 1BIIB has a Debt to Equity ratio (0.35) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 2.78 | ||
| Altman-Z | 3.25 |
ROIC/WACC1.16
WACC8.36%
2.3 Liquidity
- A Current Ratio of 2.72 indicates that 1BIIB has no problem at all paying its short term obligations.
- 1BIIB's Current ratio of 2.72 is in line compared to the rest of the industry. 1BIIB outperforms 57.95% of its industry peers.
- 1BIIB has a Quick Ratio of 2.04. This indicates that 1BIIB is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of 1BIIB (2.04) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.72 | ||
| Quick Ratio | 2.04 |
3. Growth
3.1 Past
- 1BIIB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.51%.
- 1BIIB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.31% yearly.
- 1BIIB shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
- The Revenue has been decreasing by -7.62% on average over the past years.
EPS 1Y (TTM)2.51%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%17.89%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.79%
3.2 Future
- Based on estimates for the next years, 1BIIB will show a small growth in Earnings Per Share. The EPS will grow by 0.59% on average per year.
- 1BIIB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.63% yearly.
EPS Next Y-7.36%
EPS Next 2Y-3.15%
EPS Next 3Y-0.51%
EPS Next 5Y0.59%
Revenue Next Year1.98%
Revenue Next 2Y-1.62%
Revenue Next 3Y-1.2%
Revenue Next 5Y-0.63%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- 1BIIB is valuated reasonably with a Price/Earnings ratio of 10.13.
- Compared to the rest of the industry, the Price/Earnings ratio of 1BIIB indicates a rather cheap valuation: 1BIIB is cheaper than 96.59% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of 1BIIB to the average of the S&P500 Index (28.60), we can say 1BIIB is valued rather cheaply.
- With a Price/Forward Earnings ratio of 10.98, the valuation of 1BIIB can be described as very reasonable.
- 1BIIB's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BIIB is cheaper than 97.73% of the companies in the same industry.
- 1BIIB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.13 | ||
| Fwd PE | 10.98 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1BIIB is valued cheaper than 94.32% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1BIIB indicates a rather cheap valuation: 1BIIB is cheaper than 96.59% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11 | ||
| EV/EBITDA | 7.46 |
4.3 Compensation for Growth
- 1BIIB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.15%
EPS Next 3Y-0.51%
5. Dividend
5.1 Amount
- No dividends for 1BIIB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOGEN INC / 1BIIB.MI FAQ
What is the ChartMill fundamental rating of BIOGEN INC (1BIIB.MI) stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1BIIB.MI.
What is the valuation status of BIOGEN INC (1BIIB.MI) stock?
ChartMill assigns a valuation rating of 7 / 10 to BIOGEN INC (1BIIB.MI). This can be considered as Undervalued.
Can you provide the profitability details for BIOGEN INC?
BIOGEN INC (1BIIB.MI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of BIOGEN INC (1BIIB.MI) stock?
The Price/Earnings (PE) ratio for BIOGEN INC (1BIIB.MI) is 10.13 and the Price/Book (PB) ratio is 1.37.
What is the expected EPS growth for BIOGEN INC (1BIIB.MI) stock?
The Earnings per Share (EPS) of BIOGEN INC (1BIIB.MI) is expected to decline by -7.36% in the next year.